-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company received the “Notice of Acceptance” issued by the State Drug Administration, and the company's marketing license application for the new indications of hichipopa ethanolamine tablets was accepted by the State Drug Administration.
Share
Listen to the news
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company received the “Notice of Acceptance” issued by the State Drug Administration, and the company's marketing license application for the new indications of hichipopa ethanolamine tablets was accepted by the State Drug Administration.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending